218 filings
Page 2 of 11
8-K
sol2yw 0lf4
8 Dec 21
Corcept Therapeutics Announces Extension of
8:16am
8-K
0e6is
3 Nov 21
Corcept Therapeutics Announces Third Quarter Financial Results
4:22pm
8-K
xdrh 5kqoxz
13 Aug 21
William Guyertojoin Corceptas Chief Development Officer
12:00am
8-K
m023 9sudk89s6
29 Jul 21
Corcept Therapeutics Announces Second Quarter Financial Results
4:14pm
8-K
2ahbd13q rwq0k
15 Jun 21
Corcept Therapeutics Settles Patent Litigation with Sun Pharmaceutical
8:32am
8-K
h4ejig
10 Jun 21
Corcept Therapeutics Appoints Joshua M. Murray to Board of Directors
1:15pm
8-K
mghdco22xg95qrj
2 Jun 21
Submission of Matters to a Vote of Security Holders
4:40pm
8-K
pxb yltb6
6 May 21
Corcept Therapeutics Provides Clinical Update and Announces First Quarter 2021 Financial Results
4:17pm
8-K
ql5diu00 e7r1hrl99i3
1 Mar 21
Departure of Directors or Certain Officers
5:16pm
8-K
v7pfyqpzw
23 Feb 21
Corcept Therapeutics Announces Fourth Quarter
4:14pm
8-K
zheitr0cs
8 Feb 21
Full-year 2020 Preliminary Selected Financial Results
4:12pm
8-K
axlg4y ip7gz
3 Feb 21
Other Events
8:31am
8-K
sdi89d5nmg
23 Nov 20
Corcept Therapeutics Appoints Gillian M. Cannon, PHD, to Board of Directors
5:24pm
8-K
x29cx2wtisv3smi
19 Nov 20
U.S. Patent Trial and Appeals Board Affirms Validity
12:00am
8-K
3g1n9bahs66eu 3kx3c
3 Nov 20
Corcept Therapeutics Announces Third Quarter 2020
4:12pm
8-K
1zr 1lob566103c
4 Aug 20
Corcept Therapeutics Announces Second Quarter 2020 Financial Results and Provides Corporate Update
4:35pm
8-K
pv0rvn
14 Jul 20
Departure of Directors or Certain Officers
5:05pm
8-K
4z8s86t6draolskkbyr
29 May 20
Submission of Matters to a Vote of Security Holders
2:23pm
8-K
ra622g shv22
4 May 20
Corcept Therapeutics Announces First Quarter 2020 Financial Results and Provides Corporate Update
4:27pm
8-K
hhtx3n9dswn8 7s5ac3
13 Mar 20
Corcept Therapeutics Appoints Gregg Alton to Board of Directors
12:00am